Health

Coca-cola enters the milk business

The Coca-Cola soft drink company has launched a new beverage on the market. It is said to be an "improved" version of cow's milk with less sugar and more protein. The company says it expects the product to be a "money-spinner".

Coca-Cola has unveiled a new milk in the U.S. that the company says has made some "improvements" over the original natural product. In exchange, it's said to cost twice as much as regular milk, Business Insider reports. The drink is called FairLife, is lactose-free and has 50 percent more protein, 30 percent more calcium and 50 percent less sugar than regular milk.

The group says it hopes the product will bring the company a "windfall" of money.

Health

Experts warn of stroke crisis in europe

In Europe alone, ten million people are affected by atrial fibrillation, a condition that is too rarely diagnosed and inadequately treated, reports Action for Stroke Prevention, an alliance of health experts and patient organizations. Atrial fibrillation, a cardiac arrhythmia, is associated with a fivefold increased risk of stroke compared to the general population, he says.

John Camm, professor of clinical cardiology at St George`s University in London, United Kingdom, explained what is meant by the stroke crisis when asked by Deutsche Gesundheits Nachrichten: "The term crisis means that we have an increasing risk of stroke and implies that this risk will increase despite available treatment options."No one can be held accountable for this, they said. Nevertheless, Camm is highly critical of the fact that the problem has not been taken seriously enough so far: "We are simply not able to persuade national health systems to prioritize this problem."

Warnings of a stroke crisis had already been ied in 2009. Since then, little has apparently happened. Camm: "That risk is higher because the population continues to age". The combination of cardiovascular diseases and increasing age leads to an increase in the annual rate of strokes, according to Camm. Strokes due to atrial fibrillation are more serious than those due to other causes, he said. This reduces the prospect of patients being able to return to their home environment.

Health

Debate on health insurance contributions has broken out anew

The record surplus of the statutory health insurance funds (GKV) is currently 28.3 billion euros. 15.2 billion is with the insurers themselves, another 13.1 billion euros is in the health fund. In view of the approaching federal elections, there has now been a push by the CSU that the health fund should be abolished and contributions by health insurers should once again be set individually. Max Staubinger, vice chairman of the CSU parliamentary group in the Bundestag, told the Passauer Neue Presse: "It is nonsense to take such a pile of money from the people."

The SPD wants to use the opportunity to completely reform the health care system and introduce a citizens' insurance system. "The billions in surpluses mean that the conditions for introducing a citizens' insurance scheme are more favorable than ever," SPD health expert Karl Lauterbach told arzteblatt. As a first step, the reserves should be paid out to the health insurance funds, on condition that the contribution rates are reduced.
The Green health politician Birgitt Bender also demanded the abolition of the "socially unjust additional contributions".

Health Minister Daniel Bahr (FDP) did not want to comment on these proposals. It makes no sense to start a discussion about this now, said a spokesman for Bahr, who said that the current system would remain in place. Due to the reduction of the federal subsidy to the health fund, the health insurance funds would already have to do without enough funds. For the current and next year, Finance Minister Wolfgang Schauble (CDU) has cut the federal subsidy by about 4.5 billion euros.

Health

Coalition: pharmaceutical companies to stock more vaccines

Politicians from the CDU/CSU and SPD pleaded on Monday for stricter rules for the stockpiling of vaccines. Thus, the SPD advocated the Pharmaceutical companies too coercive , Keep more preparations on hand. The CDU/CSU demanded that health insurers allow more companies to bid in tenders. However, the number of manufacturers of inoculants is small after several mergers in the industry.

The British pharmaceutical giant GlaxoSmithKline (GSK) Has reported difficulties in the production of vaccines against chickenpox (varicella), which will last until the second quarter. The reasons are quality problems in a factory in Belgium. A quadruple vaccine (MMRV) against measles, mumps, rubella and chickenpox and a single vaccine against varicella are affected.

Despite the Bottlenecks sees Health Minister Hermann Grohe No acute need for action. "At the moment, there is no reason for uncertainty or panic," a spokeswoman stressed. The shortfall at GSK could be compensated for by products from other manufacturers. Experts have recently expressed doubts about this, especially with regard to the protection against Chickenpox . The other major manufacturer of such vaccines, Sanofi Pasteur MSD, has stated that it cannot fully compensate for the loss of a competitor.

Health

Cannabis therapy: cost coverage by health insurance companies secured

The German Pain League e. V. (DSL) and the German Society for Pain Medicine e. V. (DGS) welcome the unanimous adoption of the law on the use of cannabis as medicine in the German Bundestag. Afterwards in the future seriously ill patients can be supplied at expense of the legal health insurance with Cannabis medicines.

The present law not only simplifies the prescription of cannabis as medicine, but in many cases also ensures the amption of costs by the health insurance companies. Thus, health insurance companies may refuse to reimburse the costs associated with the prescription of cannabis-containing medicines only in justified exceptional cases, and at the same time will be obliged to make the decision on the amption of costs within five weeks (in the case of patients under SAPV within three days) from the date of application.

"Hereby falls presumably starting from March 2017 for many humans with chronic therapy-difficult pain the crucial hurdle for the medical use of Cannabis-containing medicines and we may hope that with this parliamentary group-spreading decision of the German Bundestag both the frustrating waiting for a decision over the amption of costs and the high number at rejecting notices finally an end has", summarizes PD Dr. Michael A. uberall, President of the German Pain League e.V. (DSL) and vice president of the German Society for Pain Medicine e.V. (DGS), his expectations regarding. of the positive effects of this law together.

Health

Finance minister wants to cut subsidies for health insurers

The German finance minister wants to take two billion euros away from the statutory health insurance funds in order to get a lot closer to his goal of a balanced national budget next year. According to current calculations, the minister lacks four billion euros for this purpose. Half of the required amount would already be covered by the health insurance budget.

Schauble wants to draw the other half equally from all other finance departments. The finance minister can cut the budgets of his colleagues across the board via a so-called global underspend, reports the news magazine Spiegel.

This is the second time that Schauble has used the health fund. Back in March 2012, he had announced – due to the favorable economic situation at the time – that he wanted to further consolidate the budget, arzteblatt reports. Even then, two billion euros were set aside in the health fund to cushion an expected deficit of the health insurance funds. However, redistribution to health insurers was not necessary.

Health

A first

A first

Gabriele Gien © Sebastian Widmann (KNA)

A first

Gien becomes president of Catholic University of Eichstatt-Ingolstadt

Gabriele Gien becomes first woman to head Catholic University of Eichstatt-Ingolstadt. In the past years the search for a president had failed several times. Gien has previously served as acting provost of universities.

Health

Obituary for dr. Wolfgang bengel

We were just in the final arrangements for the presentation of his honor by the DGZMK when the very sad news of Wolfgang Bengel's death overtook our deliberations. Since he had to interrupt our joint board work at the Dentists' Day two years ago, we have all lived with the diagnosis of a disease that can no longer be cured – the final news still shakes us beyond measure. The Board of Directors and very many of our colleagues mourn the loss of a fine and special man. Through his calmness, his great quiet humor and his approachable manner, everyone could sense that Wolfgang Bengel was a generous person. Wolfgang Bengel never said "no" when it came to taking over a task or an office. His calmness and composure in coping with these tasks have been appreciated by all, as well as his profound knowledge and his very obliging and friendly manner. When sharing a task with him, he did not care who had done more or who was the more successful. Wolfgang Bengel stands exemplary for the many silent experts of his profession. Overtherapy, which could have bypassed the concerns of his patients, was unthinkable for him. Without always letting it be known, he lived the "human" in his doctor-patient relationships every day.

Obituary for dr. Wolfgang bengel

Photo: B. Schunk/German Medical Publishers Fortunately, he passed on his special knowledge in the field of dental photography and diseases of the oral mucosa in many lectures, book publications and also privately. Beyond the borders, his audience was impressed by his confident and friendly way of imparting knowledge. Everyone could sense that he did it with pleasure and free from the airs and graces of the know-it-all. A special honor was his appointment to the board of the highly endowed "Lennart Nilsson Award" in the field of science photography and his laudation in honor of the world-famous science photographer Lennart Nilsson.
During his time as vice-president he established a unique service of the DGZMK with the oral mucosa and X-ray consultation for the colleagues and thus left us all a special memory of his knowledge. From 1998 to 2006 he was Secretary General of the German Society of Periodontology and from 2006 to 2013 Vice President of the DGZMK. The founding of the "Ethics" and "Epidemiology" working groups is partly due to his initiative. Like Wolfgang Bengel The way in which Wolfgang Bengel dealt with and wanted to deal with the difficult diagnosis in the little time he had left in life is expressed in his words of encouragement to his personal environment: "In all that is to come, remain cheerful!" Wolfgang For his sake, we would like to be, but it is especially difficult in view of the loss of such a dear person and esteemed colleague. We will Wolfgang and his work always in memory. Dr. Norbert Grosse for the board of the DGZMK Dr. Wolfgang Bengel (Heiligenberg/Lake Constance) – Studied dentistry in Bonn
– State examination and doctorate in 1974
– Niederlang 1977
– Main fields of work: dental photography and diseases of the oral mucosa (book publications 1984, 1986, 1998 and 2000, 2001, 2006)
– Lecturer and course activity on both topics in Germany and abroad
– constant cooperation, editorial activity in div. Magazines: u.a. "The Quintessence", "Periodontology"
– 1992 until the end of 2004 member of the board of the Association of Statutory Health Insurance Dentists in Hesse
– 1998 to 2006 Secretary General of the German Society of Periodontology e.V.
– since October 2005 Member of the Board of the German Society for Dental, Oral and Maxillofacial Medicine (DGZMK)
– 2006 – 2013 Vice President of the DGZMK
– since 2007 resident in Heiligenberg/Lake Constance
– GP in Heiligenberg since 2012